"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
64,"no","yes","Cardiometabolic polygenic risk scores and osteoarthritis outcomes: a Mendelian randomization study from the Malmӧ Diet and Cancer Study and the UK Biobank",2019,"Arthritis and Rheumatology","10.1002/art.40812","Hindy","George Hindy","George.Hindy@med.lu.se","Department of Clinical Sciences in Malmö, Lund University, Jan Waldenströms gata 35, Clinical Research Center, 205 02 Malmö, Sweden","Effect of BMI on osteoarthritis","To investigate the causal role of cardiometabolic risk factors in osteoarthritis (OA) using associated genetic variants","One-sample","osteoarthritis","diagnosis","skeletal","A clinical record of either knee or hip OA","Current study","Mean age 58.5","both","3559","27691","3559","27691",NA,"Case/control","White ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both","Mean age 27.3","both","26435","249796","One-sample where they got exposure SNPs from external GWAS",NA,"European","Not discussed","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Proxy SNPs were identified using SNAP version 2.2.2","SNPs with a genotype success rate of <90% or deviation from Bonferroni-corrected Hardy-Weinberg Equilibrium in each set of SNPs of the specific traits were excluded",NA,NA,"31","32","Not discussed","No",NA,"wald ratio",NA,NA,NA,NA,NA,NA,"Not discussed","STATA 13.1 and R","“MendelianRandomization” package in R","Not discussed","Performed replication analyses in the UK Biobank using two-sample conventional MR","Did not correct for multiple testing",NA,NA,"OR","1.65",NA,"95","1.1399999999999999","2.41","1.2999999999999999E-2",NA,NA,"Used two different OA end-points, one based on clinical diagnosis and the other on the surgical intervention of arthroplasty, the study-defined phenotype is heterogeneous and prone to other non-random factors that influence indications for joint replacement","The PRSs included pleiotropic SNPs, which may have biased our results","Not discussed","not discussed",NA,1158
64,"no","yes","Cardiometabolic polygenic risk scores and osteoarthritis outcomes: a Mendelian randomization study from the Malmӧ Diet and Cancer Study and the UK Biobank",2019,"Arthritis and Rheumatology","10.1002/art.40812","Hindy","George Hindy","George.Hindy@med.lu.se","Department of Clinical Sciences in Malmö, Lund University, Jan Waldenströms gata 35, Clinical Research Center, 205 02 Malmö, Sweden","Effect of BMI on osteoarthritis","To investigate the causal role of cardiometabolic risk factors in osteoarthritis (OA) using associated genetic variants","One-sample","osteoarthritis","joint replacement","skeletal","A record of either a hip or knee joint arthroplasty surgery","Current study","Mean age 60.2","both","2780","27691","2780","27691",NA,"Case/control","White ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both","Mean age 27.3","both","26435","249796","One-sample where they got exposure SNPs from external GWAS",NA,"European","Not discussed","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Proxy SNPs were identified using SNAP version 2.2.2","SNPs with a genotype success rate of <90% or deviation from Bonferroni-corrected Hardy-Weinberg Equilibrium in each set of SNPs of the specific traits were excluded",NA,NA,"31","32","Not discussed","No",NA,"wald ratio",NA,NA,NA,NA,NA,NA,"Not discussed","STATA 13.1 and R","“MendelianRandomization” package in R","Not discussed","Performed replication analyses in the UK Biobank using two-sample conventional MR","Did not correct for multiple testing",NA,NA,"OR","1.31",NA,"95","0.86","2","0.21199999999999999",NA,NA,"Used two different OA end-points, one based on clinical diagnosis and the other on the surgical intervention of arthroplasty, the study-defined phenotype is heterogeneous and prone to other non-random factors that influence indications for joint replacement","The PRSs included pleiotropic SNPs, which may have biased our results","Not discussed","not discussed",NA,1159
64,"no","yes","Cardiometabolic polygenic risk scores and osteoarthritis outcomes: a Mendelian randomization study from the Malmӧ Diet and Cancer Study and the UK Biobank",2019,"Arthritis and Rheumatology","10.1002/art.40812","Hindy","George Hindy","George.Hindy@med.lu.se","Department of Clinical Sciences in Malmö, Lund University, Jan Waldenströms gata 35, Clinical Research Center, 205 02 Malmö, Sweden","Effect of BMI on osteoarthritis","To investigate the causal role of cardiometabolic risk factors in osteoarthritis (OA) using associated genetic variants","One-sample","osteoarthritis","diagnosis or joint replacement","skeletal","Either a diagnosis or joint replacement","Current study","Mean age 59.2","both","4226","27691","4226","27691",NA,"Case/control","White ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both","Mean age 27.3","both","26435","249796","One-sample where they got exposure SNPs from external GWAS",NA,"European","Not discussed","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Proxy SNPs were identified using SNAP version 2.2.2","SNPs with a genotype success rate of <90% or deviation from Bonferroni-corrected Hardy-Weinberg Equilibrium in each set of SNPs of the specific traits were excluded",NA,NA,"31","32","Not discussed","No",NA,"wald ratio",NA,NA,NA,NA,NA,NA,"Not discussed","STATA 13.1 and R","“MendelianRandomization” package in R","Not discussed","Performed replication analyses in the UK Biobank using two-sample conventional MR","Did not correct for multiple testing",NA,NA,"OR","1.42",NA,"95","1","2.02","5.8000000000000003E-2",NA,NA,"Used two different OA end-points, one based on clinical diagnosis and the other on the surgical intervention of arthroplasty, the study-defined phenotype is heterogeneous and prone to other non-random factors that influence indications for joint replacement","The PRSs included pleiotropic SNPs, which may have biased our results","Not discussed","not discussed",NA,1160
64,"no","yes","Cardiometabolic polygenic risk scores and osteoarthritis outcomes: a Mendelian randomization study from the Malmӧ Diet and Cancer Study and the UK Biobank",2019,"Arthritis and Rheumatology","10.1002/art.40812","Hindy","George Hindy","George.Hindy@med.lu.se","Department of Clinical Sciences in Malmö, Lund University, Jan Waldenströms gata 35, Clinical Research Center, 205 02 Malmö, Sweden","Effect of BMI on osteoarthritis","To investigate the causal role of cardiometabolic risk factors in osteoarthritis (OA) using associated genetic variants","Two-sample summary-level","osteoarthritis","diagnosis","skeletal","A clinical record of either knee or hip OA","Current study","Mean age 58.5","both","3559","27691","3559","27691",NA,"Case/control","White ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both","Mean age 27.3","both","26435","249796","One-sample where they got exposure SNPs from external GWAS",NA,"European","Not discussed","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Proxy SNPs were identified using SNAP version 2.2.2","SNPs with a genotype success rate of <90% or deviation from Bonferroni-corrected Hardy-Weinberg Equilibrium in each set of SNPs of the specific traits were excluded",NA,NA,"31","32","Not discussed","No",NA,"Inverse variance weighted","MR Egger","Weighted median","Multi-variable MR",NA,NA,"Consistent with main analysis","Not discussed","STATA 13.1 and R","“MendelianRandomization” package in R","Not discussed","Performed replication analyses in the UK Biobank using two-sample conventional MR","Did not correct for multiple testing",NA,NA,"OR","1.41",NA,"95","0.96","2.08","8.8999999999999996E-2",NA,NA,"Used two different OA end-points, one based on clinical diagnosis and the other on the surgical intervention of arthroplasty, the study-defined phenotype is heterogeneous and prone to other non-random factors that influence indications for joint replacement","The PRSs included pleiotropic SNPs, which may have biased our results","Not discussed","not discussed",NA,1161
64,"no","yes","Cardiometabolic polygenic risk scores and osteoarthritis outcomes: a Mendelian randomization study from the Malmӧ Diet and Cancer Study and the UK Biobank",2019,"Arthritis and Rheumatology","10.1002/art.40812","Hindy","George Hindy","George.Hindy@med.lu.se","Department of Clinical Sciences in Malmö, Lund University, Jan Waldenströms gata 35, Clinical Research Center, 205 02 Malmö, Sweden","Effect of BMI on osteoarthritis","To investigate the causal role of cardiometabolic risk factors in osteoarthritis (OA) using associated genetic variants","Two-sample summary-level","osteoarthritis","joint replacement","skeletal","A record of either a hip or knee joint arthroplasty surgery","Current study","Mean age 60.2","both","2780","27691","2780","27691",NA,"Case/control","White ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both","Mean age 27.3","both","26435","249796","One-sample where they got exposure SNPs from external GWAS",NA,"European","Not discussed","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Proxy SNPs were identified using SNAP version 2.2.2","SNPs with a genotype success rate of <90% or deviation from Bonferroni-corrected Hardy-Weinberg Equilibrium in each set of SNPs of the specific traits were excluded",NA,NA,"31","32","Not discussed","No",NA,"Inverse variance weighted","MR Egger","Weighted median","Multi-variable MR",NA,NA,"Consistent with main analysis","Not discussed","STATA 13.1 and R","“MendelianRandomization” package in R","Not discussed","Performed replication analyses in the UK Biobank using two-sample conventional MR","Did not correct for multiple testing",NA,NA,"OR","1.19",NA,"95","0.77","1.82","0.442",NA,NA,"Used two different OA end-points, one based on clinical diagnosis and the other on the surgical intervention of arthroplasty, the study-defined phenotype is heterogeneous and prone to other non-random factors that influence indications for joint replacement","The PRSs included pleiotropic SNPs, which may have biased our results","Not discussed","not discussed",NA,1162
64,"no","yes","Cardiometabolic polygenic risk scores and osteoarthritis outcomes: a Mendelian randomization study from the Malmӧ Diet and Cancer Study and the UK Biobank",2019,"Arthritis and Rheumatology","10.1002/art.40812","Hindy","George Hindy","George.Hindy@med.lu.se","Department of Clinical Sciences in Malmö, Lund University, Jan Waldenströms gata 35, Clinical Research Center, 205 02 Malmö, Sweden","Effect of BMI on osteoarthritis","To investigate the causal role of cardiometabolic risk factors in osteoarthritis (OA) using associated genetic variants","Two-sample summary-level","osteoarthritis","diagnosis or joint replacement","skeletal","Either a diagnosis or joint replacement","Current study","Mean age 59.2","both","4226","27691","4226","27691",NA,"Case/control","White ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both","Mean age 27.3","both","26435","249796","One-sample where they got exposure SNPs from external GWAS",NA,"European","Not discussed","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Proxy SNPs were identified using SNAP version 2.2.2","SNPs with a genotype success rate of <90% or deviation from Bonferroni-corrected Hardy-Weinberg Equilibrium in each set of SNPs of the specific traits were excluded",NA,NA,"31","32","Not discussed","No",NA,"Inverse variance weighted","MR Egger","Weighted median","Multi-variable MR",NA,NA,"Consistent with main analysis","Not discussed","STATA 13.1 and R","“MendelianRandomization” package in R","Not discussed","Performed replication analyses in the UK Biobank using two-sample conventional MR","Did not correct for multiple testing",NA,NA,"OR","1.24",NA,"95","0.86","1.79","0.26600000000000001",NA,NA,"Used two different OA end-points, one based on clinical diagnosis and the other on the surgical intervention of arthroplasty, the study-defined phenotype is heterogeneous and prone to other non-random factors that influence indications for joint replacement","The PRSs included pleiotropic SNPs, which may have biased our results","Not discussed","not discussed",NA,1163
114,"no","yes","The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study",2013,"Clinical and Epidemiological Research","10.1136/annrheumdis-2013-203772","Panoutsopoulou","Kalliope Panoutsopoulou","kp6@sanger.ac.uk","Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire","Effect of body mass index on osteoarthritis","Variation in the fat mass and obesity- associated (FTO) gene influences susceptibility to obesity. A variant in the FTO gene has been implicated in genetic risk to osteoarthritis (OA). We examined the role of the FTO polymorphism rs8044769 in risk of knee and hip OA in cases and controls incorporating body mass index","One-sample","osteoarthritis","hip","skeletal","Hip osteoarthritis","Current study","Not discussed","both","Not discussed","Not discussed",NA,NA,NA,"Case/control","European ancestry","BMI","BMI","Current study","Not discussed","both","Not discussed",NA,NA,"Case/control","European","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","1",NA,NA,NA,NA,"Not discussed",NA,"Not discussed","Not discussed",NA,NA,NA,NA,"Observational analysis consistent with MR","Association of SNP with phenotype","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","case/control","Not clear","Not clear","Not clear","Not clear","Not clear","Not clear","Not clear","Not discussed","Not discussed","study has combined both OA cases from population-based cohorts and severe OA cases from case/control studies recruited via secondary care","Not discussed","Not discussed","the statistical power of the current study to detect association of the FTO SNP and OA is sufficient in the overweight stratum (73%–80%) but is modest for the normal weight and obese strata (34%–47%). Thus, we cannot exclude the possibility that a very modest association may be present among normal weight individuals, which our study failed to detect.",NA,1497
114,"no","yes","The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study",2013,"Clinical and Epidemiological Research","10.1136/annrheumdis-2013-203772","Panoutsopoulou","Kalliope Panoutsopoulou","kp6@sanger.ac.uk","Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire","Effect of body mass index on osteoarthritis","Variation in the fat mass and obesity- associated (FTO) gene influences susceptibility to obesity. A variant in the FTO gene has been implicated in genetic risk to osteoarthritis (OA). We examined the role of the FTO polymorphism rs8044769 in risk of knee and hip OA in cases and controls incorporating body mass index","One-sample","osteoarthritis","knee","skeletal","Knee osteoarthritis","Current study","Not discussed","both","Not discussed","Not discussed",NA,NA,NA,"Case/control","European ancestry","BMI","BMI","Current study","Not discussed","both","Not discussed",NA,NA,"Case/control","European","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","1",NA,NA,NA,NA,"Not discussed",NA,"Not discussed","Not discussed",NA,NA,NA,NA,"Observational analysis consistent with MR","Association of SNP with phenotype","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","case/control","Not clear","Not clear","Not clear","Not clear","Not clear","Not clear","Not clear","Not discussed","Not discussed","study has combined both OA cases from population-based cohorts and severe OA cases from case/control studies recruited via secondary care","Not discussed","Not discussed","the statistical power of the current study to detect association of the FTO SNP and OA is sufficient in the overweight stratum (73%–80%) but is modest for the normal weight and obese strata (34%–47%). Thus, we cannot exclude the possibility that a very modest association may be present among normal weight individuals, which our study failed to detect.",NA,1498
114,"no","yes","The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study",2013,"Clinical and Epidemiological Research","10.1136/annrheumdis-2013-203772","Panoutsopoulou","Kalliope Panoutsopoulou","kp6@sanger.ac.uk","Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire","Effect of body mass index on osteoarthritis","Variation in the fat mass and obesity- associated (FTO) gene influences susceptibility to obesity. A variant in the FTO gene has been implicated in genetic risk to osteoarthritis (OA). We examined the role of the FTO polymorphism rs8044769 in risk of knee and hip OA in cases and controls incorporating body mass index","One-sample","osteoarthritis","all","skeletal","Hip or knee osteoartrits","Current study","Not discussed","both","Not discussed","Not discussed",NA,NA,NA,"Case/control","European ancestry","BMI","BMI","Current study","Not discussed","both","Not discussed",NA,NA,"Case/control","European","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","not discussed","Not discussed","Not discussed","1",NA,NA,NA,NA,"Not discussed",NA,"Not discussed","Not discussed",NA,NA,NA,NA,"Observational analysis consistent with MR","Association of SNP with phenotype","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","case/control","Not clear","Not clear","Not clear","Not clear","Not clear","Not clear","Not clear","Not discussed","Not discussed","study has combined both OA cases from population-based cohorts and severe OA cases from case/control studies recruited via secondary care","Not discussed","Not discussed","the statistical power of the current study to detect association of the FTO SNP and OA is sufficient in the overweight stratum (73%–80%) but is modest for the normal weight and obese strata (34%–47%). Thus, we cannot exclude the possibility that a very modest association may be present among normal weight individuals, which our study failed to detect.",NA,1499
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","self report","skeletal","self-reported osteoarthritis","Current study","48-73","both","12658","50898",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"65",NA,"77","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","SD","log odds","OR","1.61473300405508","0.0877872370781035","95","1.35499051412212","1.92426636733617","8.3426979324841E-7","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2127
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","hospital diagnosed","skeletal","Hospital-diagnosed  all-site osteoarthritis","Current study","48-73","both","10083","40425",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"65",NA,"77","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","SD","log odds","OR","1.66089804213252","0.0819034123146551","95","1.41020850557558","1.95615208350606","4.6955353383282299E-8","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2128
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","hip and/or knee hospital diagnosed","skeletal","Hospital-diagnosed hip and/or knee osteoarthritis","Current study","48-73","both","6586","26384",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"65",NA,"77","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","SD","log odds","OR","1.92498507966314","0.104546709148874","95","1.56214856004307","2.37209677216841","3.55939939744587E-8","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2129
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","hip hospital diagnosed","skeletal","Hospital-diagnosed hip osteoarthritis","Current study","48-73","both","2396","9593",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"65",NA,"77","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","SD","log odds","OR","2.01113670514741","0.192084271620663","95","1.3702149723116","2.95185129963052","5.5096317069369704E-4","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2130
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","knee hospital diagnosed","skeletal","Hospital-diagnosed knee osteoarthritis","Current study","48-73","both","4462","17885",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"65",NA,"77","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","SD","log odds","OR","1.96743011004964","0.124486577680733","95","1.53424384518895","2.52292440348896","9.0827685483851905E-7","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2131
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","self report","skeletal","self-reported osteoarthritis","Current study","48-73","both","12658","50898",NA,NA,NA,"Case/control","European","BMI","extreme BMI","Berndt 2013 Extreme body mass index European both","18+","both","16068","70996","Only used stage 1 of meta-analysis results","healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"7",NA,"Not clear","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","0.3438196×ln(odds)","log odds","OR","1.04461169703301","0.00911712077179384","95","1.02156569317987","1.06817760704309","3.0404028728376899E-3","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2142
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","hospital diagnosed","skeletal","Hospital-diagnosed  all-site osteoarthritis","Current study","48-73","both","10083","40425",NA,NA,NA,"Case/control","European","BMI","extreme BMI","Berndt 2013 Extreme body mass index European both","18+","both","16068","70996","Only used stage 1 of meta-analysis results","healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"7",NA,"Not clear","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","0.3438196×ln(odds)","log odds","OR","1.05756600554153","0.0102225229534348","95","1.03144056718323","1.08435317716022","1.55039902174114E-3","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2143
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","hip and/or knee hospital diagnosed","skeletal","Hospital-diagnosed hip and/or knee osteoarthritis","Current study","48-73","both","6586","26384",NA,NA,NA,"Case/control","European","BMI","extreme BMI","Berndt 2013 Extreme body mass index European both","18+","both","16068","70996","Only used stage 1 of meta-analysis results","healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"7",NA,"Not clear","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","0.3438196×ln(odds)","log odds","OR","1.084462017417","0.0126604631540944","95","1.05138147534356","1.11858340174375","6.8310033973806295E-4","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2144
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","hip hospital diagnosed","skeletal","Hospital-diagnosed hip osteoarthritis","Current study","48-73","both","2396","9593",NA,NA,NA,"Case/control","European","BMI","extreme BMI","Berndt 2013 Extreme body mass index European both","18+","both","16068","70996","Only used stage 1 of meta-analysis results","healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"7",NA,"Not clear","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","0.3438196×ln(odds)","log odds","OR","1.06708911566882","0.0225622882934962","95","1.00977401476178","1.12765744031103","2.8130828427837901E-2","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2145
179,"no","yes","Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis",2018,"Nature Genetics","s41588-018-0079-y","Zengini","Eleftheria Zeggini","eleftheria@sanger.ac.uk","Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.","Effect of adiposity traits and body mass extremes on osteoarthritis","We undertook Mendelian randomization (MR) analyses to strengthen causal inference regarding modifiable exposures that might influence osteoarthritis risk","Two-sample summary-level","osteoarthritis","knee hospital diagnosed","skeletal","Hospital-diagnosed knee osteoarthritis","Current study","48-73","both","4462","17885",NA,NA,NA,"Case/control","European","BMI","extreme BMI","Berndt 2013 Extreme body mass index European both","18+","both","16068","70996","Only used stage 1 of meta-analysis results","healthy","Europeans","not discussed","Affymetrix GeneTitan® Multi-Channel (MC) Instrument","r2< 0.001","Horizontal pleiotropy tests. We additionally assessed the robustness of our findings to potential violations of the assumption of no horizontal pleiotropy by applying two tests of horizontal pleiotropy. One test was the MR–Egger intercept, which can be interpreted as the average instrument-outcome coefficient when the instrument-exposure coefficient is zero. If there is no horizontal pleiotropy, the intercept should be zero. Therefore, the intercept provides an indication of overall unbalanced horizontal pleiotropy. The second test was Cochran’s Q test of heterogeneity, which relies on the assumption that all valid genetic instruments estimate the same causal effect.","P< 5.0× 10−8","Not discussed","Not discussed","Not discussed",NA,"7",NA,"Not clear","Not discussed","Yes","We performed power calculations to estimate the power of our two-sample MR analysis to detect odds ratios of 1.2, 1.5 and 2.0. The analysis were performed through simulations (10,000 iterations), with power defined as the proportion of times that 95% confidence intervals of the IVW method excluded 1.","Inverse variance weighted","MR Egger","Weighted median","MBE (Mode-based estimate)",NA,NA,"Consistent with main analysis","F-statistic","R","TwoSampleMR","Not discussed","Yes","Not discussed","0.3438196×ln(odds)","log odds","OR","1.09817369324025","0.0153591781768992","95","1.05766745156517","1.14023123122516","8.8636490453453099E-4","Not discussed","Not discussed","Not focussed on MR","For all other exposure phenotypes, there was no convincing evidence of a causal effect on osteoarthritis risk, thus suggesting that the genetic correlations detected by linkage disequilibrium (LD)-score regression may be mostly due to horizontal pleiotropy, although for some phenotypes the MR analyses were underpowered.","Not discussed","for some phenotypes the MR analyses were underpowered",NA,2146
181,"no","yes","Causal associations between risk factors and common diseases inferred from GWAS summary data",2018,"NATURE COMMUNICATIONS","10.1038/s41467-017-02317-2","Zhu","Jian Yang","jian.yang@uq.edu.au","Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia","Method paper: Effect of body mass index and waits hip ratio adjusted for body mass index on 22 traits and a disease count trait","We develop a method (HEIDI-outlier) to detect and eliminate genetic instruments that have apparent pleiotropic effects on both risk factor and disease, and another method (multi-trait-based conditional and joint analysis, or mtCOJO) to estimate the effect of a risk factor on disease conditioning on other risk factors. All methods developed in this study only require summary-level data (with LD between genetic variants from a reference sample with individual-level data), providing a great flexibility to integrate data from multiple studies.","Generalized summary data-based MR (GSMR)","osteoarthritis","community","skeletal","Osteoarthritis  (Community)","Current study",NA,"both","33155","140030",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"healthy","Europeans","not discussed","HapMap phase II CEU","r2< 0.05","We propose a method (called HEIDI-outlier) to detect pleiotropic SNPs at which the estimates of bxy are significantly different from expected under a causal model, and remove them from the GSMR analysis (Methods).","P< 5.0× 10−8","Not discussed","Not reported","We cleaned the GERA genotype data using the standard quality control (QC) filters (excluding SNPs with missing rate ≥0.02, Hardy–Weinber equilibrium test P-value ≤ 1 × 10−6 or minor allele count < 1, and removing individuals with missing rate ≥0.02), and imputed the genotype data to the 1000G using IMPUTE2.",NA,"81",NA,"77","Probably used all ancestries GWAS not EU as stated, plus use of HEIDI-outlier detection","Yes","We simulated 1,000 independent SNPs from a binomial distribution z ~B(2,f). We then generated x and y under the assumption that x has a causal effect ton y, using the same method as above with 7'"" 2 = 0.6, 7""# 2 = 0.005, n1 =	50,000	and n2 = 20,000. We conducted analyses using GSMR,	MR-Egger1, MR-IVW2,	generalized MR-IVW3, and the Pickrell methods4 based on a random	subset	of the	genome-wide	significant SNPs associated with x, the	number of instruments	m ~U(10,mt) where mt is the total number of genome-wide	significant SNPs. We  ran the simulations with	10,000	replicates.","GSMR","MR Egger","MR-IVW","Generalised MR-IVW",NA,NA,"Consistent with main analysis","Not discussed","R","Not discussed","Not discussed","Not discussed","Not discussed","SD","log odds","OR","1.49995528572071",NA,"95","1.33755291436909","1.68207615189768","4.0755216879547003E-12",NA,NA,"there are several caveats in interpreting the GSMR results. First, if the exposure is a composite trait that comprises multiple sub-phenotypes, we could not rule out the possibility that the effect of exposure on disease is driven by one of the sub-phenotypes. Second, the effect of a risk factor on disease can be non-linear. Fourth, our analyses ignored age-specific and sex-specific effects because of the lack of data from age- and sex-stratified analyses.","results were not driven by pleiotropy and reverse causality. In some cases, the relationship between a risk factor and a disease could be a mixture of multiple models. the intercepts from MR-Egger (a significant deviation of the intercept from 0 is evidence for the presence of pleiotropy) were very small relative to the slopes (Supplementary Fig. 24), and there was no inflation in the test-statistics (Supplementary Fig. 24b, c), suggesting that the degree of pleiotropy was negligible if there was any.","Not discussed","Third, although we have identified a large number of associations, we would expect that associations of small effect size would be missed in our study.",NA,2184
